international peers): $25.0B/year Issue #3 : Hospital Commercial Reference Pricing: $73.0B/year Issue #4 : PBM Reform: $30.0B/year Issue #5 : Administrative Waste (hospital operational variance, multi-payer billing complexity, prior authorization): $200.0B/year Issue #6 : Hospital Supply Waste (within-peer operational variance, case-mix adjusted): $28.0B/year Issue #7 : GLP-1 Pricing (price reduction opportunity from US-international alignment + generic entry): $40.0B/year Running total: $396.6 billion per year, 13.2% of the $3 trillion annual gap between US and Japanese per-capita healthcare spending
Hernandez and J.T
PSC and IBD Overview of PSC Primary Sclerosing Cholangitis (PSC) is a chronic, progressive cholestatic disease that causes fibrosis and inflammation of the intrahepatic and extrahepatic bile ducts, likely due to an abnormal immune response in genetically susceptible individuals
The starting dose was 2.5 mg and was increased by 2.5 mg every 4 weeks until hitting the maximum dosage of 10 mg or 15 mg
What is the difference between allergies and sinus infections
in euthyroid athletes, supraphysiologic doses can promote weight loss and heightened metabolic rate, but carry risks of atrial fibrillation, tachyarrhythmia, and bone loss [122]
